Table 3.
Peri-operative treatments. (A) Chemotherapy; (B) Radiotherapy. RT, radiotherapy.
| Chemotherapy regimen | Patients, number (%) |
|---|---|
| Induction phase | |
| FLOT | 17 (43.5) |
| FOLFOX | 13 (33.5) |
| EOX | 1 (2) |
| ECF | 2 (5) |
| Cisplatin + fluorouracil | 6 (15) |
| Trastuzumab | 4 (10) |
| Adjuvant phase | |
| None | 13 (33) |
| FLOT | 7 (18) |
| FOLFOX | 7 (18) |
| XELOX | 1 (2.5) |
| FOLFIRI | 1 (2.5) |
| Cisplatin + fluorouracil | 1 (2.5) |
| Capecitabine | 1 (2.5) |
| DeGramont | 1 (2.5) |
| Trastuzumab | 3 (8) |
| (a) | |
| Radiotherapy | Patients, number (%) |
| RT alone | 1 (2.5) |
| Concomitant RT with capecitabine | 2 (5) |
| Sequential RT (after adjuvant chemotherapy | 3 (8) |
| (b) | |